44 research outputs found
Low CO/CO<sub>2</sub> ratios of comet 67P measured at the Abydos landing site by the <i>Ptolemy</i> mass spectrometer
Comets are generally considered to contain the best-preserved material from the beginning of our planetary system, although the mechanism of their formation and subsequent evolution are still poorly understood. Here we report the direct in situ measurement of H2O, CO, and CO2 by the Ptolemy mass spectrometer onboard the Philae lander, part of the European Space Agency’s Rosetta mission, at the Abydos site of the Jupiter-family comet 67P/Churyumov-Gerasimenko. A CO/CO2 ratio of around 0.07 ± 0.04 is found at the surface of the comet, a value substantially lower than the one measured by ROSINA in the coma. Such a major difference is a potential indication of heterogeneity of the nucleus and not of changes in the CO/CO2 ratio of the coma with radial distance
Space Weathering on Near-Earth Objects investigated by neutral-particle detection
The ion-sputtering (IS) process is active in many planetary environments in
the Solar System where plasma precipitates directly on the surface (for
instance, Mercury, Moon, Europa). In particular, solar-wind sputtering is one
of the most important agents for the surface erosion of a Near-Earth Object
(NEO), acting together with other surface release processes, such as Photon
Stimulated Desorption (PSD), Thermal Desorption (TD) and Micrometeoroid Impact
Vaporization (MIV). The energy distribution of the IS-released neutrals peaks
at a few eVs and extends up to hundreds of eVs. Since all other release
processes produce particles of lower energies, the presence of neutral atoms in
the energy range above 10 eV and below a few keVs (Sputtered High-Energy Atoms
- SHEA) identifies the IS process. SHEA easily escape from the NEO, due to
NEO's extremely weak gravity. Detection and analysis of SHEA will give
important information on surface-loss processes as well as on surface elemental
composition. The investigation of the active release processes, as a function
of the external conditions and the NEO surface properties, is crucial for
obtaining a clear view of the body's present loss rate as well as for getting
clues on its evolution, which depends significantly on space weather. In this
work, an attempt to analyze the processes that take place on the surface of
these small airless bodies, as a result of their exposure to the space
environment, has been realized. For this reason a new space weathering model
(Space Weathering on NEO - SPAWN), is presented. Moreover, an instrument
concept of a neutral-particle analyzer specifically designed for the
measurement of neutral density and the detection of SHEA from a NEO is proposedComment: 36 page
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
Background: Oral temozolomide has shown similar efficacy to dacarbazine in phase III trials with median progression-free survival (PFS) of 2.1 months. Bevacizumab has an inhibitory effect on the proliferation of melanoma and sprouting endothelial cells. We evaluated the addition of bevacizumab to temozolomide to improve efficacy in stage IV melanoma. Patients and methods: Previously untreated metastatic melanoma patients with Eastern Cooperative Oncology Group performance status of two or more were treated with temozolomide 150 mg/m2 days 1-7 orally and bevacizumab 10 mg/kg body weight i.v. day 1 every 2 weeks until disease progression or unacceptable toxicity. The primary end point was disease stabilisation rate [complete response (CR), partial response (PR) or stable disease (SD)] at week 12 (DSR12); secondary end points were best overall response, PFS, overall survival (OS) and adverse events. Results: Sixty-two patients (median age 59 years) enrolled at nine Swiss centres. DSR12 was 52% (PR: 10 patients and SD: 22 patients). Confirmed overall response rate was 16.1% (CR: 1 patient and PR: 9 patients). Median PFS and OS were 4.2 and 9.6 months. OS (12.0 versus 9.2 months; P = 0.014) was higher in BRAF V600E wild-type patients. Conclusions: The primary end point was surpassed showing promising activity of this bevacizumab/temozolomide combination with a favourable toxicity profile. Response and OS were significantly higher in BRAF wild-type patient
Influence of spacecraft outgassing on the exploration of tenuous atmospheres with in situ mass spectrometry
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/94765/1/jgra20796.pd
Entwicklungsszenarien einer alpinen Aue bei einem natürlichen Geschiebedefizit : die Triftaue im Oberhasli
In der zweiten Hälfte des 20. Jahrhunderts hat sich im Zuge des Gletscherrückzugs eine alpine Aue im Triftgebiet gebildet. Zu Beginn prägten dynamische Geschiebeumlagerungsprozesse die Flusslandschaft am Triftwasser und führten zu einer typischen Sukzession einer alpinen Aue. Mit dem weiteren Rückzug des Triftgletschers hat sich Anfang dieses Jahrhunderts der natürliche Triftsee gebildet, der einen Geschiebeeintrag in die darunterliegende Triftaue praktisch vollständig unterbindet. Damit wird die Geschiebedynamik im Triftwasser auf ein absolutes Minimum reduziert. Daher ist es dem Gewässer so gut wie nicht mehr möglich, seinen Verlauf im Zuge von Hochwasserereignissen zu verändern und neue morphologische Strukturen zu bilden. Aufgrund der topografischen Verhältnisse (breiter Kessel) können die natürlicherweise auftretenden Hochwasserereignisse nicht mehr genug Kraft entwickeln, um grossflächige Vegetationsbestände zu entwurzeln. Damit verbunden ist eine rasche Ausbreitung an Grünerlenbeständen, die mittelfristig die heutige Triftaue fast vollständig besiedeln werden. Im Rahmen des Triftprojekts (Vergrösserung des Triftsees mit neuem Kraftwerk auf Höhe der bestehenden Triftfassung) wurden u.a. detaillierte Studien zum Ist-Zustand sowie zur Entwicklung der Triftaue mit und ohne Projekt durchgeführt. Basierend auf diesen Untersuchungen wurden für die Realisierung des Projekts neben dem Restwasserregime zusätzlich auch Hochwasserdotierungen festgelegt
The <i>Castalia</i> mission to Main Belt Comet 133P/Elst-Pizarro
We describe Castalia, a proposed mission to rendezvous with a Main Belt Comet (MBC), 133P/Elst-Pizarro. MBCs are a recently discovered population of apparently icy bodies within the main asteroid belt between Mars and Jupiter, which may represent the remnants of the population which supplied the early Earth with water. Castalia will perform the first exploration of this population by characterising 133P in detail, solving the puzzle of the MBC’s activity, and making the first in situ measurements of water in the asteroid belt. In many ways a successor to ESA’s highly successful Rosetta mission, Castalia will allow direct comparison between very different classes of comet, including measuring critical isotope ratios, plasma and dust properties. It will also feature the first radar system to visit a minor body, mapping the ice in the interior. Castalia was proposed, in slightly different versions, to the ESA M4 and M5 calls within the Cosmic Vision programme. We describe the science motivation for the mission, the measurements required to achieve the scientific goals, and the proposed instrument payload and spacecraft to achieve these
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07).
BACKGROUND: Oral temozolomide has shown similar efficacy to dacarbazine in phase III trials with median progression-free survival (PFS) of 2.1 months. Bevacizumab has an inhibitory effect on the proliferation of melanoma and sprouting endothelial cells. We evaluated the addition of bevacizumab to temozolomide to improve efficacy in stage IV melanoma. PATIENTS AND METHODS: Previously untreated metastatic melanoma patients with Eastern Cooperative Oncology Group performance status of two or more were treated with temozolomide 150 mg/m(2) days 1-7 orally and bevacizumab 10 mg/kg body weight i.v. day 1 every 2 weeks until disease progression or unacceptable toxicity. The primary end point was disease stabilisation rate [complete response (CR), partial response (PR) or stable disease (SD)] at week 12 (DSR12); secondary end points were best overall response, PFS, overall survival (OS) and adverse events. RESULTS: Sixty-two patients (median age 59 years) enrolled at nine Swiss centres. DSR12 was 52% (PR: 10 patients and SD: 22 patients). Confirmed overall response rate was 16.1% (CR: 1 patient and PR: 9 patients). Median PFS and OS were 4.2 and 9.6 months. OS (12.0 versus 9.2 months; P = 0.014) was higher in BRAF V600E wild-type patients. CONCLUSIONS: The primary end point was surpassed showing promising activity of this bevacizumab/temozolomide combination with a favourable toxicity profile. Response and OS were significantly higher in BRAF wild-type patients
A Rice Plastidial Nucleotide Sugar Epimerase Is Involved in Galactolipid Biosynthesis and Improves Photosynthetic Efficiency
Photosynthesis is the final determinator for crop yield. To gain insight into genes controlling photosynthetic capacity, we selected from our large T-DNA mutant population a rice stunted growth mutant with decreased carbon assimilate and yield production named photoassimilate defective1 (phd1). Molecular and biochemical analyses revealed that PHD1 encodes a novel chloroplast-localized UDP-glucose epimerase (UGE), which is conserved in the plant kingdom. The chloroplast localization of PHD1 was confirmed by immunoblots, immunocytochemistry, and UGE activity in isolated chloroplasts, which was approximately 50% lower in the phd1-1 mutant than in the wild type. In addition, the amounts of UDP-glucose and UDP-galactose substrates in chloroplasts were significantly higher and lower, respectively, indicating that PHD1 was responsible for a major part of UGE activity in plastids. The relative amount of monogalactosyldiacylglycerol (MGDG), a major chloroplast membrane galactolipid, was decreased in the mutant, while the digalactosyldiacylglycerol (DGDG) amount was not significantly altered, suggesting that PHD1 participates mainly in UDP-galactose supply for MGDG biosynthesis in chloroplasts. The phd1 mutant showed decreased chlorophyll content, photosynthetic activity, and altered chloroplast ultrastructure, suggesting that a correct amount of galactoglycerolipids and the ratio of glycolipids versus phospholipids are necessary for proper chloroplast function. Downregulated expression of starch biosynthesis genes and upregulated expression of sucrose cleavage genes might be a result of reduced photosynthetic activity and account for the decreased starch and sucrose levels seen in phd1 leaves. PHD1 overexpression increased photosynthetic efficiency, biomass, and grain production, suggesting that PHD1 plays an important role in supplying sufficient galactolipids to thylakoid membranes for proper chloroplast biogenesis and photosynthetic activity. These findings will be useful for improving crop yields and for bioenergy crop engineering